These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 32026868)

  • 1. [Severe delirium after GHB abuse].
    Sundal EV; Giil LM
    Tidsskr Nor Laegeforen; 2020 Feb; 140(2):. PubMed ID: 32026868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baclofen and gamma-hydroxybutyrate withdrawal.
    LeTourneau JL; Hagg DS; Smith SM
    Neurocrit Care; 2008; 8(3):430-3. PubMed ID: 18266111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inpatient GHB withdrawal management in an inner-city hospital in Sydney, Australia: a retrospective medical record review.
    Siefried KJ; Freeman G; Roberts DM; Lindsey R; Rodgers C; Ezard N; Brett J
    Psychopharmacology (Berl); 2023 Jan; 240(1):127-135. PubMed ID: 36508055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical management of gamma-hydroxybutyrate (GHB) withdrawal delirium with CIWA-Ar protocol.
    Liao PC; Chang HM; Chen LY
    J Formos Med Assoc; 2018 Dec; 117(12):1124-1127. PubMed ID: 29933901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma-hydroxybutyrate withdrawal syndrome.
    Dyer JE; Roth B; Hyma BA
    Ann Emerg Med; 2001 Feb; 37(2):147-53. PubMed ID: 11174231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe GHB withdrawal delirium managed with dexmedetomidine.
    Tay EM; Graham RI; Day RO
    Med J Aust; 2016 Sep; 205(6):251-2. PubMed ID: 27627929
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful Management of Gamma-hydroxybutyrate (GHB) Withdrawal Using Baclofen as a Standalone Therapy: A Case Report.
    Habibian S; Ahamad K; McLean M; Socias ME
    J Addict Med; 2019; 13(5):415-417. PubMed ID: 30907765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [GHB withdrawal delirium].
    Stijnenbosch PJ; Zuketto C; Beijaert PJ; Maat A
    Ned Tijdschr Geneeskd; 2010; 154():A1086. PubMed ID: 20132572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenobarbital to manage severe gamma-hydroxybutyrate withdrawal: A case series.
    Freeman G; Siefried KJ; Roberts DM; Rodgers C; Nic Ionmhain U; Ramanathan J; Ezard N; Brett J
    Drug Alcohol Rev; 2023 Jan; 42(1):27-32. PubMed ID: 36269081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gamma-hydroxybutyrate withdrawal syndrome: dangerous but not well-known.
    van Noorden MS; van Dongen LC; Zitman FG; Vergouwen TA
    Gen Hosp Psychiatry; 2009; 31(4):394-6. PubMed ID: 19555805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Gamma Hydroxybutyrate Withdrawal in a Pregnant Female: A Case Report.
    Joyce S; Lea S; Woolner M; Leddy A
    J Addict Med; 2024 May-Jun 01; 18(3):342-344. PubMed ID: 38345233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excited delirium syndrome after withdrawal from 10 days long recreationally used GHB.
    Corstens D
    J Forensic Leg Med; 2018 Feb; 54():74-75. PubMed ID: 29328965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two cases of severe gamma-hydroxybutyrate withdrawal delirium on a psychiatric unit: recommendations for management.
    Rosenberg MH; Deerfield LJ; Baruch EM
    Am J Drug Alcohol Abuse; 2003 May; 29(2):487-96. PubMed ID: 12765217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical toxicology of γ-hydroxybutyrate, γ-butyrolactone and 1,4-butanediol.
    Schep LJ; Knudsen K; Slaughter RJ; Vale JA; Mégarbane B
    Clin Toxicol (Phila); 2012 Jul; 50(6):458-70. PubMed ID: 22746383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enteral baclofen withdrawal managed with intravenous dexmedetomidine: A case report.
    Defayette A; Perrello A; Brewer T; Picano J; Ahmed S
    Am J Health Syst Pharm; 2020 Feb; 77(5):352-355. PubMed ID: 31930325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gamma-hydroxybutyric acid: patterns of use, effects and withdrawal.
    Miotto K; Darakjian J; Basch J; Murray S; Zogg J; Rawson R
    Am J Addict; 2001; 10(3):232-41. PubMed ID: 11579621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe gamma-hydroxybutyrate withdrawal: a case report and literature review.
    Craig K; Gomez HF; McManus JL; Bania TC
    J Emerg Med; 2000 Jan; 18(1):65-70. PubMed ID: 10645841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. gamma-Hydroxybutyrate withdrawal and chloral hydrate.
    Hutto B; Fairchild A; Bright R
    Am J Psychiatry; 2000 Oct; 157(10):1706. PubMed ID: 11007738
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review.
    McDonough M; Kennedy N; Glasper A; Bearn J
    Drug Alcohol Depend; 2004 Jul; 75(1):3-9. PubMed ID: 15225884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inpatient management of GHB/GBL withdrawal.
    Delic M
    Psychiatr Danub; 2019 Sep; 31(Suppl 3):354-356. PubMed ID: 31488752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.